TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
LEO Pharma A/S
Closing information (x1000 NOK)
Closing information | 2020/12 | 2019/12 | 2018/12 |
Turnover | 14,322,598 | 14,266,500 | 13,981,951 |
Earnings before taxes | -1,526,538 | -2,251,215 | 1,901,868 |
Total assets | 33,715,280 | 32,692,136 | 21,871,478 |
Current assets | 12,169,897 | 12,439,120 | 9,352,192 |
Current liabilities | 8,619,284 | 7,376,856 | 6,365,078 |
Equity capital | 9,819,312 | 10,679,079 | 12,797,313 |
- share capital | 353,365 | 330,090 | 335,782 |
Employees (average) | 1,000 | 1,000 | 1,000 |
Financial ratios
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Solvency | 29.1% | 32.7% | 58.5% |
Turnover per employee | 14,323 | 14,266 | 13,982 |
Profit as a percentage of turnover | -10.7% | -15.8% | 13.6% |
Return on assets (ROA) | |||
Current ratio | 141.2% | 168.6% | 146.9% |
Return on equity (ROE) | -15.5% | -21.1% | 14.9% |
Change turnover | -949,846 | 521,543 | -95,362 |
Change turnover % | -6% | 4% | -1% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2020/12 | 2019/12 | 2018/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.